Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data

被引:22
|
作者
Liner, Kendall [1 ]
Brown, Celeste [2 ]
McGirt, Laura Y. [3 ]
机构
[1] Med Coll Georgia Augusta Hlth, Div Dermatol, Augusta, GA USA
[2] Univ North Carolina Chapel Hill, Carolinas Med Ctr, Sch Med, Charlotte, NC 28203 USA
[3] Levine Canc Inst, Carolinas Med Ctr, Dept Hematol Oncol, Charlotte, NC USA
来源
关键词
mycosis fungoides; nitrogen mustard; mechlorethamine gel; cutaneous T-cell lymphoma; CTCL; Valchlor (R); NITROGEN-MUSTARD THERAPY; CHEMOTHERAPY; EXPERIENCE; MANAGEMENT;
D O I
10.2147/DDDT.S137106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations.
引用
收藏
页码:241 / 254
页数:14
相关论文
共 50 条
  • [41] TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (MYCOSIS-FUNGOIDES) WITH 13-CIS-RETINOIC ACID
    KESSLER, JF
    LEVINE, N
    MEYSKENS, FL
    LYNCH, PJ
    JONES, SE
    LANCET, 1983, 1 (8338): : 1345 - 1347
  • [42] Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sezary syndrome
    Duvic, Madeleine
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 529 - 544
  • [43] Palliative Local Radiotherapy in the Treatment of Tumor-stage Cutaneous T-cell Lymphoma/ Mycosis Fungoides
    Chen-chen Xu
    Tao Zhang
    Tao Wang
    Jie Liu
    Yue-hua Liu
    Chinese Medical Sciences Journal, 2014, 29 (01) : 33 - 37
  • [44] A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma: logistic regression of clinical and laboratory data
    Stevens, SR
    Ke, MS
    Birol, A
    Terhune, MH
    Parry, EJ
    Ross, C
    Mostow, EN
    Gilliam, AC
    Cooper, KD
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (03) : 513 - 522
  • [45] Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
    Whittaker, Sean J.
    Foss, Francine M.
    CANCER TREATMENT REVIEWS, 2007, 33 (02) : 146 - 160
  • [46] Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas - The severity-weighted assessment tool (SWAT)
    Stevens, SR
    Ke, MS
    Parry, EJ
    Mark, J
    Cooper, KD
    ARCHIVES OF DERMATOLOGY, 2002, 138 (01) : 42 - 48
  • [47] Persistent agmination of lymphomatoid papulosis: An equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma
    Heald, Peter
    Subtil, Antonio
    Breneman, Deborah
    Wilson, Lynn D.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) : 1005 - 1011
  • [48] FOLLICULAR MYCOSIS-FUNGOIDES - A CLINICAL AND HISTOLOGIC VARIANT OF CUTANEOUS T-CELL LYMPHOMA - REPORT OF 2 CASES
    LACOUR, JP
    CASTANET, J
    PERRIN, C
    ORTONNE, JP
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (02) : 330 - 334
  • [49] Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings (vol 39, pg 3979,2022)
    Wehkamp, Ulrike
    Ardigo, Marco
    Papadavid, Evangelia
    Querfeld, Christiane
    Nikbakht, Neda
    ADVANCES IN THERAPY, 2023, 40 (03) : 1299 - 1300
  • [50] Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
    Christiane Querfeld
    Winnie W. Nelson
    Deval Gor
    Chris L. Pashos
    Quan V. Doan
    Marco Turini
    James T. Angello
    Larisa J. Geskin
    Dermatology and Therapy, 2022, 12 : 2781 - 2795